Osteonecrosis is a rare side effect of Olimab. It refers to the damage caused to the bone of jaw. To avoid this, you should maintain good oral hygiene and receive routine dental check ups while taking Olimab. Contact your doctor and dentist immediately if you experience any problems with your mouth or teeth such as loose teeth, discharge, pain or swelling, or non-healing of sores. These could be signs of osteonecrosis of jaw.

There is no optimal duration of treatment of osteoporosis with Olimab. The patient’s response and tolerability to the medicine is continuously monitored through periodic assessments, especially after 5 years of use of Olimab. Depending on this, the duration of taking Olimab is decided.

No, pregnant women should not take Olimab. You must use an effective method of birth control during and for at least 5 months after the last dose of Olimab if you can become pregnant.

Olimab is not a chemotherapy drug. It is a protein (monoclonal antibody) that interferes with the action of another protein in order to treat bone loss and osteoporosis. Treatment with Olimab makes the bones stronger and less likely to break.

Olimab is available as an injection and is given by a healthcare professional. It is given once in 6 months. Your doctor may also advise you to take calcium and vitamin D while taking Olimab.

Yes, hair loss is a common side effect of Olimab though it does not affect everyone. Discuss with your doctor if you have concerns regarding your hair loss.

Olimab should be stored in a refrigerator at 36°F to 46°F (2°C to 8°C) in the original carton. Warm temperatures can make it ineffective, and therefore proper storage is necessary. When you remove it from the refrigerator, keep it at room temperature [up to 77°F (25°C)] in the original carton and use it within 14 days.